Julie A. Vetalice, Author at ORTHOWORLD

Tyber Medical Launches TyWedge Evans And Cotton Osteotomy Wedge Systems

Tyber Medical commenced full market launch of its TyWedge™ Osteotomy Wedge System, featuring TyPEEK® proprietary titanium plasma-sprayed PEEK coating specifically indicated for fusion.

Feb 09, 2016

Ellipse Technologies Withdraws IPO

Investments The Numbers

Ellipse Technologies withdrew its plans for a US $75MM initial public offering, filed in 4Q15, in light of its pending acquisition by NuVasive.

Feb 09, 2016

Tentative Date for FDA Advisory Panel Review of Cartiva SCI

ORTHOFLASH Sports Medicine

FDA tentatively scheduled a 2Q16 meeting of the Orthopaedic and Rehabilitation Devices Panel to review Cartiva’s Premarket Approval Application for the Synthetic Cartilage Implant in the treatment of great toe osteoarthritis.

Feb 09, 2016

OrthAlign’s Multi-country Distribution Agreement with Smith & Nephew

Company Updates Competitive Landscape

OrthAlign entered into a multi-country distribution agreement with Smith & Nephew for its KneeAlign® Total Knee Arthroplasty component alignment technology.

Feb 09, 2016

First Implantation of VGI Medical’s VerteLP Lateral Lumbar Cage with Bi-Cortical Fixation

ORTHOFLASH Spine

VGI Medical announced successful implantation of the first VerteLP® Lateral Lumbar Cage.

Feb 08, 2016

CollPlant Reports Final Trial Results for VergenixSTR in the Treatment of Tendinopathy

Orthobiologics ORTHOFLASH

CollPlant announced positive final clinical trial results for Vergenix™STR, intended for the treatment of tendinopathy.

Feb 04, 2016

Medovex Receives Reimbursement for DenerveX Facet Joint Syndrome Treatment in Germany

ORTHOFLASH Spine

The German reimbursement authority released new reimbursement payment coding for the Medovex DenerveX™ system for the treatment of facet joint syndrome.

Feb 04, 2016

Histogenics Completes 50% Enrollment in NeoCart Phase III Trial

Orthobiologics ORTHOFLASH

Histogenics has completed >50% of the required enrollment in its ongoing NeoCart® Phase III clinical trial in the treatment of knee cartilage defects.

Feb 03, 2016

Bone Therapeutics Extends Collaboration with Kasios

Company Updates Competitive Landscape

Bone Therapeutics extended its collaboration with Kasios to combine ALLOB® bone cell therapy with a 3D-printed synthetic cage intended to support the spinal fusion process.

Feb 02, 2016

Seikagaku Ceases Development of Enthesopathy Application

Orthobiologics ORTHOFLASH

Seikagaku and Kaken Pharmaceutical will discontinue development of SI-657, an additional indication of enthesopathy for the ARTZ injectable joint function-improving agent.

Feb 02, 2016

Get the ORTHOWORLD Newsletter!

Contact Us